[2026] Participating in the KoNECT-MOHW-MFDS International Conference

From October 13 to 15, 2026, we participated in the 2026 KoNECT-MOHW-MFDS International Conference, held at The Grand Lotte Hotel in Seoul.

This premier international event brought together pharmaceutical and biotech companies, contract research organizations (CROs), and medical researchers from around the world to share the latest strategies in clinical trials and drug development, and to build frameworks for global collaboration.

At our exhibition booth, we introduced our ultra-sensitive biomarker analysis services utilizing SIMOA and NULISA to CROs and life science companies. Alongside the service showcase, we ran our signature “Stop at 2.17 Seconds!” event — a stopwatch challenge themed around P-tau217, a key marker in blood-based Alzheimer’s diagnostics. The energy at the booth was electric, with five lucky winners taking home a Cheetaring, our proprietary smart ring. The excitement keeps growing, and we can’t wait to see who the next winner will be!

We also joined the networking dinner held during the conference, where we had the opportunity to connect with key stakeholders from global pharma companies, CROs, and regulatory bodies — building the relationships that will drive our next chapter forward.

We look forward to continuing to expand our global clinical network and advancing the reach of our biomarker analysis services. 

Stay tuned for what’s next from Bredis Healthcare!